Currently, the pharmaceutical supply chain is a 'black box' for most consumers; you might know the name of the company on the bottle, but not where the factory is located. If a specific factory in another country has a massive safety recall or hygiene issue, it is very difficult for an American consumer to know if their specific bottle of medicine came from that location. This bill provides a 'birth certificate' for drugs, bringing the same level of transparency to medicine that we already have for many food products.

If this becomes law, it could force higher standards across the global drug industry because companies will know that their manufacturing locations are public. If it doesn't pass, the origin of most medications will remain hidden from the people taking them, leaving consumers to rely entirely on federal inspectors to catch problems behind the scenes.